@entity5 of the heart: epidemiology and management of @entity5 and XXXX .

@entity1 @entity2826 @entity242 @entity5 @entity2 @entity4617 @entity3 @entity299 @entity791
@entity4617 , benign or malignant, are rare and most are benign. The most common @entity5 is the @entity299 . @entity4617 are @entity242 . The pericardium can be the site of benign and malignant @entity4617 , though @entity3 occur here far more commonly than do @entity5 . Successful treatment for @entity4617 is usually achieved by surgical resection. Surgery for primary @entity5 is, however, much less successful as complete resection is usually not possible. Primary @entity299 may be successfully treated by chemotherapy. Tumors that metastasize to the heart from other organs occur 100- to 1000-fold more commonly than primary @entity4617 . Metastatic spread to the heart has been identified in approximately one-fifth of all @entity1 who have @entity5 with @entity2 being the most common @entity5 . Symptoms of cardiac @entity3 vary, and they depend on the site and extent of the lesions. Treatment varies depending on the pathology of the @entity5 . However, the aim of treatment is usually symptomatic relief. With the advent of @entity791 , @entity2826 and high grade B cell lymphomas have also been identified in cardiac tissue. The aim of this article is to review the epidemiology, clinical presentation, pathology and treatment of @entity4617 .
